Opposite effects of dextran sulfate 500, the polyene antibiotic MS-8209, and Congo red on accumulation of the protease-resistant isoform of PrP in the spleens of mice inoculated intraperitoneally with the scrapie agent

Journal of Virology

Volumn 74, Issue 12, 2000, Pages 5432-5440

  Beringue, Vincent ^a,c   Adjou, Karim T ^a   Lamoury, François ^a   Maignien, Thomas ^a   Deslys, Jean Philippe ^a   Race, Richard ^b   Dormont, Dominique ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONGO RED; DEXTRAN SULFATE; MS 8209; POLYENE ANTIBIOTIC AGENT; PRION PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOMODULATION; MOUSE; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; SCRAPIE; SPLEEN;

AMPHOTERICIN B; ANIMALS; BRAIN; CONGO RED; CRICETINAE; DEXTRAN SULFATE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOPEPTIDASE K; FEMALE; INJECTIONS, INTRAPERITONEAL; KINETICS; MICE; MICE, INBRED C57BL; MICE, SCID; ORGAN SPECIFICITY; PROTEIN BINDING; PROTEIN ISOFORMS; PRPSC PROTEINS; SCRAPIE; SPLEEN; TIME FACTORS;

EID: 0034044948     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.12.5432-5440.2000     Document Type: Article

References (51)

1. Adjou, K. T., R. Demaimay, C. I. Lasmézas, J. P. Deslys, M. Seman, and D. Dormont. 1995. MS-8209, a new amphotericin B derivative, provides enhanced efficacy in delaying hamster scrapie. Antimicrob. Agents Chemother. 39:2810-2812.
2. Adjou, K. T., R. Demaimay, C. I. Lasmézas, M. Seman, J. P. Deslys, and D. Dormont. 1996. Differential effects of a new amphotericin B derivative, MS-8209, on mouse BSE and scrapie: implications for the mechanism of action of polyene antibiotics. Res. Virology 147:213-218.
3. Adjou, K. T., J. P. Deslys, R. Demaimay, M. Seman, and D. Dormont. 1998. Prospects for the pharmacological treatment of human prion diseases. CNS Drugs 10:83-89.
4. Beringue, V., R. Demaimay, K. T. Adjou, S. Demart, F. Lamoury, M. Seman, C. I. Lasmézas, J. P. Deslys, and D. Dormont. 1998. Polyene antibiotics in experimental transmissible subacute spongiform encephalopathies, p. 177-185. In D. R. O. Morrison (ed.), Prions and brains diseases in animals and humans, vol. 295. Plenum Press, New York, N.Y.
5. Beringue, V., C. I. Lasmézas, K. T. Adjou, R. Demaimay, F. Lamoury, J. P. Deslys, M. Seman, and D. Dormont. 1999. Inhibiting scrapie neuroinvasion by polyene antibiotic treatment of SCID mice. J. Gen. Virol. 80:1873-1877.
6. Beringue, V., M. Demoy, C. I. Lasmézas, B. Gouritin, C. Weingarten, J. P. Deslys, J. P. Andreux, P. Couvreur, and D. Dormont. 2000. Role of spleen macrophages in the clearance of scrapie agent early in pathogenesis. J. Pathol. 190:495-502.
7. Bolton, D. C., M. P. McKinley, and S. B. Prusiner. 1982. Identification of a protein that purities with the scrapie prion. Science 218:1309-1311.
8. Büeler, H., A. Aguzzi, A. Sailer, R. A. Greiner, P. Autenried, M. Aguet, and C. Weissmann. 1993. Mice devoid of PrP are resistant to scrapie. Cell 73: 1339-1347,
9. Caspi, S., M. Halimi, A. Yanai, S. BenSasson, A. Taraboulos, and R. Gabizon. 1998. The anti-prion activity of Congo red. Putative mechanism. J. Biol. Chem. 273:3484-3489.
10. Caughey, B., K. Brown, G. J. Raymond, G. E. Katenstein, and W. Thresher. 1994. Binding of the protease-sensitive form of prior protein PrP to sulfated glycosaminoglycan and Congo red. J. Virol. 68:2135-2141.
11. Caughey, B., D. Ernst, and R. E. Race. 1993. Congo red inhibition of scrapie agent replication. J. Virol. 67:6270-6272.
12. Caughey, B., and R. E. Race. 1992. Potent inhibition of scrapie-associated PrP accumulation by Congo red. J. Neurochem. 59:768-771.
13. Caughey, B., and G. J. Raymond. 1993. Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J. Virol. 67:643-650.
14. Demaimay, R., K. T. Adjou, C. I. Lasmézas, F. Lazarini, K. Cherifi, M. Seman, J. P. Deslys, and D. Dormont. 1994. Pharmalogical studies of a new derivative of amphotericin B. MS-8209, in mouse and hamster scrapie. J. Gen. Virol. 75:2499-2503.
15. Demaimay, R., K. T. Adjou, V. Beringue, S. Demart, C. I. Lasmézas, J. P. Deslys, M. Seman, and D. Dormont. 1997. Late treatment with polyene antibiotics can prolong the survival time of scrapie-infected animals. J. Virol. 71:9685-9689.
16. Demaimay, R., J. Harper, H. Gordon, D. Weaver, B. Chesebro, and B. Caughey. 1998. Structural aspects of Congo red as an inhibitor of protcase-resistant prion protein formation. J. Neurochem. 71:2534-2541.
17. Demaimay, R., R. Race, and B. Chesebro. 1999. Effectiveness of polyene antibiotics in treatment of transmissible spongiform encephalopathy in transgenic mice expressing syrian hamster PrP only in neurons. J. Virol. 73:3511-3513.
18. Diamanstein, T., B. Wagner, I. Beyso, M. V. Odenwald, and G. Schulzt. 1971. Stimulation of humoral antibody formation by polyanions. II. The influence of sulfate esters of polymers on the immune response in mice. Eur. J. Immunol. 1:340-343.
19. Diringer, H., and B. Ehlers. 1991. Chemoprophylaxis of scrapie in mice. J. Gen. Virol. 72:457-460.
20. Dorries, R., A. Schimpl, and E. Wecker. 1974. Action of dextran sulfate as a direct and general B-mitogen. Eur, J. Immunol. 4:230-233.
21. Ehlers, B., and H. Diringer. 1984. Dextran sulphate 500 delays and prevents mouse scrapie by impairment of agent replication in spleen. J. Gen. Virol. 65:1325-1330.
22. Eklund, C, M., R. C. Kennedy, and W. J. Hadlow. 1967. Pathogenesis of scrapie virus infection in the mouse. J. Infect. Dis. 117:15-22.
23. Farquhar, C. F., and A. G. Dickinson. 1986. Prolongation of scrapie incubation period by an injection of dextran sulphate 500 within the month before or after infection. J. Gen. Virol. 67:463-473.
24. Farquhar, C. F., J. Dornan, R. A. Somerville, A. M. Tunstall, and J. Hope. 1994. Effect of Sinc genotype, agent isolate and route of infection on the accumulation of protease-resistant PrP in non-central nervous system tissues during the development of murine scrapie. J. Gen. Virol. 75:495-504.
25. Fowler, E. F., and A. W. Thomson. 1978. Effect of carrageenan on activity of the mononuclear phagocyte system in the mouse. Br. J. Exp. Pathol. 59: 213-219.
26. Grathwohl, K. U. D., M. Horiuchi, N. Ishiguro, and M. Shinagawa. 1996. Improvement of PrPsc-detection in mouse spleen early at the preclinical stage of scrapie with collagenase-completed tissue homogenization and Sarkosyl-NaCl extraction of PrPsc. Arch. Virol. 141:1863-1874.
27. Hadlow, W. J., R. C. Kennedy, and R. E. Race. 1982. Natural infection of Suffolk sheep with scrapie virus. J. Infect. Dis. 146:657-664.
28. Hill, A. F., M. Zeidler, J. Ironside, and J. Collinge. 1997. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 349:99-100.
29. Hilton, D. A., E. Fathers, P. Edwards, J. W. Ironside, and J. Zajicek. 1998. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 352:703-704.
30. Ingrosso, L., A. Ladogana, and M. Pocchiari. 1995. Congo red prolongs the incubation period in scrapie-infected hamsters. J. Virol. 69:506-508.
31. Kimberlin, R. H., and C. A. Walker. 1983. The antiviral compound HPA-23 can prevent scrapie when administered at the time of infection. Arch. Virol. 78:9-18.
32. Kimberlin, R. H., and C. A. Walker. 1988. Pathogenesis of experimental scrapie. Ciba Found. Symp. 135:37-62.
33. Kimberlin, R. H., and C. A. Walker. 1979. Pathogenesis of mouse scrapie dynamics of agent replication in spleen, spinal cord and brain after infection by different routes. J. Comp. Pathol. 89:551-562.
34. Kimberlin, R. H., and C. A. Walker. 1986. Suppression of scrapie infection in mice by heteropolyanion 23, dextran sulfate, and some other polyanions. Antimicrob. Agents Chemother. 30:409-413.
35. Lasmézas, C. I., J. Y. Cesbron, J. P. Deslys, R. Demaimay, K. T. Adjou, R. Rioux, C. Lemaire, C. Locht, and D. Dormont. 1996. Immune system-dependent and -independent replication of the scrapie agent. J. Virol. 70:1292-1295.
36. Lasmézas, C. I., J. P. Deslys, R. Demaimay, K. T. Adjou, J. J. Hauw, and D. Dormont. 1996. Strain specific and common pathogenic events in murine models of scrapie and bovine spongiform encephalopathy. J. Gen. Virol. 77: 1601-1609.
37. Lasmézas, C. I., J. P. Deslys, O. Robain, A. Jaegly, V. Beringue, J. M. Peyrin, J. G. Fournier, J. J. Hauw, J. Rossier, and D. Dormont. 1997. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275:402-405.
38. Maignien, T., C. I. Lasmézas, V. Beringue, D. Dormont, and J. P. Deslys. 1999. Pathogenesis of the oral route of infection of mice with scrapie and bovine spongiform encephalopathy agents. J. Gen. Virol. 80:3035-3042.
39. McBride, P. A., M. I. Wilson, P. Eikelenboom, A. Tunstail, and M. E. Bruce. 1998. Heparan sulfate proteoglycan is associated with amyloid plaques and neuroanatomically targeted PrP pathology throughout the incubation period of scrapie-infected mice. Exp. Neurol. 149:447-454.
40. McCarthy, R. E., L. W. Arnold, and G. F. Babcock. 1977. Dextran sulfate: an adjuvent for cell-mediated immune responses. Immunology 32:963-974.
41. Merz, P. A., R. A. Somerville, H. M. Wisniewski, L. Manuelidis, and E. E. Manuelidis. 1983. Scrapie-associated fibrils in Creutzfeldt-Jakob disease. Nature 306:474-476.
42. Millson, G. C., R. H. Kimberlin, E. J. Manning, and S. C. Collis. 1979. Early distribution of radioactive liposomes and scrapie infectivity in mouse tissues following administration by different routes. Vet. Microbiol. 4:89-99.
43. Pan, K. M., M. Baldwin, J. Nguyen, M. Gasset, A. Serban, D. Groth, I. Mehlhorn, Z. Huang, R. J. Flelterick, F. E. Cohen, and S. B. Prusiner. 1993. Conversion of a-helices into β-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA 90:10962-10966.
44. Pocchiari, M., P. Casaccia, and A. Ladogana. 1989. Amphotericin B: a novel class of antiscrapie drugs. J. Infect. Dis. 160:795-802.
45. Prusiner, S. B. 1982. Novel proteinaceous infectious particles cause scrapie. Science 216:136-144.
46. Prusiner, S. B., S. P. Cochran, D. F. Groth, D. E. Downey, K. A. Bowman, and H. M. Martinez. 1982. Measurement of the scrapie agent using an incubation time interval assay. Ann. Neurol. 11:353-358.
47. Prusiner, S. B., M. P. McKinley, K. A. Bowman, D. C. Bolton, P. E. Bendheim, D. F. Groth, and G. G. Glenner. 1983. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35:349-358.
48. Race, R. E., and D. Ernst. 1992. Detection of proteinase K-resistant prion protein and infectivity in mouse spleen by 2 weeks after scrapie agent inoculation. J. Gen. Virol. 73:3319-3323.
49. Rubenstein, R., R. J. Kascsak, P. A. Merz, M. C. Papini, R. I. Carp, N. K. Robakis, and H. M. Wisniewski. 1986. Detection of scrapie-associated fibril (SAF) proteins using anti-SAF antibody in non-purified tissue preparations. J. Gen. Virol. 67:671-681.
50. Snow, A. D., T. N. Wight, D. Nochlin, Y. Koike, K. Kimata, S. J. DeArmond, and S. B. Prusiner. 1990. Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie. Lab. Investig. 63:601-611.
51. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.